DOCSLIB.ORG

2019-20 Transactions Raised

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2019-20 Transactions Raised 2019-20 transactions raised Row Labels Sum of AMOUNT_DUE_ORIGINAL "Expolab" Fortschrittliche £15,127 "Trivium-XXI" ltd. £1,576 (NAMMDR) National Agency for Medicines & £405 (PTB) Braunschweig und Berlin £288 1 A PHARMA GMBH £2,428 10 MOTIVES LIMITED £300 10461164 CANADA INC. £3,600 12-14 PHARMACY LIMITED £2,710 1A PHARMA GMBH £2,289 1drop Inc. £3,024 3 PHARMALABS PLC (RAMAS LAUNCH ONLY) £352 360biolabs £710 3M DEUTSCHLAND GMBH £614 3M HEALTH CARE LIMITED £26,432 3M UNITED KINGDOM PUBLIC LIMITED COMPANY £4,950 4 COURT LIMITED £288 4COURT HEALTHCARE LIMITED £288 7 DAZE LLC £600 700THESPIANS LIMITED £6,345 77 Elektronika Ltd. £336 8 PHARMA LIMITED £172 A & H PHARMACIES LIMITED £288 A C MACKIE LIMITED £3,739 A D HEALTHCARE LIMITED £288 A FRASER JONES LIMITED £288 A G PARFETT AND SONS LIMITED £172 A G BANNERMAN LIMITED £172 A G, B J, A C, L R SMITH £172 A MANN LIMITED £288 A MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL £3,357 A NELSON AND COMPANY LIMITED £9,994 A S VIRDI £288 A V PHARMA LIMITED £2,759 A&C American Chemicals Inc. -£501 A. MENARINI FARMACEUTICA INTERNAZIONALE SRL £5,280 A. Menarini Research & Business Service GmbH £906 A.ALGEO LIMITED £774 A.F. BLAKEMORE AND SON LIMITED £172 A.J.M.MANSELL LIMITED £2,710 A.VOGEL LIMITED £4,420 A1 PHARMACEUTICALS PLC £23,339 A2Z PHARMACY LIMITED £288 AAH PHARMACEUTICALS LIMITED £7,589 Aalborg Hospital North £2,112 AARJAY HEALTHCARE LIMITED £288 AASH PHARM LIMITED -£288 AB Analitica S.R.L £2,690 AB BIOTECHNOLOGY LIMITED £468 AB Diagnostic Systems GmbH £1,630 ABACUS MEDICINE LTD £337 ABBEYVET EXPORT LLP £2,769 Abbott £648 Abbott Biologicals BV £329,818 Abbott Diagnostics Korea Inc. £5,534 Abbott Diagnostics Medical Co. Ltd. £2,169 Abbott GmbH £744 Abbott India Limited £3,700 Abbott Japan Co. Ltd £360 Abbott Laboratories £3,103 ABBOTT LABORATORIES LIMITED £28,739 Abbott Laboratories Services £110,652 Abbott Molecular Inc £4,082 Abbott Products Egypt L.L.C £2,335 Abbott Rapid Diagnostics Jena GmbH £3,568 ABBOTT VASCULAR INTERNATIONAL £5,040 ABBVIE INCORPORATED £42,500 ABBVIE LIMITED £225 ABBVIE LTD £88,672 AbbVie Operations Singapore Pte Ltd £6,048 ABC DRUGSTORES LIMITED £1,260 Abcam plc £6,752 ABDI FARMA UNIPESSOAL LIMITADA £66,439 Aberdeen Royal Infirmary £10,869 Abionic SA £624 ABLATIVE SOLUTIONS, INC. £3,510 ABRA HEALTHCARE LTD £288 ABRA WHOLESALE LIMITED £172 ABS LABORATORIES LIMITED £5,363 Absorption Systems Boston, LLC. £336 Abviris Deutschland GmbH £1,248 Abzena (Cambridge) Limited £331 AC IMMUNE SA £4,410 Academia Nacional de Medicina £280 ACADEMIC UNIT OF RADIOLOGY UNIVERSITY OF SHEFFIELD £468 ACCELSIORS CRO AND CONSULTANCY SERVICES LIMITED £7,695 ACCENDO PHARMA LIMITED £2,224 Access Bio Korea, Inc. £6,900 Access Bio, Inc. £120 ACCMEDE PHARMACEUTICALS LIMITED £288 ACCORD HEALTHCARE LIMITED £1,396,976 ACCORD-UK LIMITED £912,452 ACCRINGTON LATE NIGHT PHARMACY LIMITED £288 ACE PHARMACEUTICALS BV £44,447 ACER PHARMA LIMITED £1,517 ACHEASON PHARMACY LIMITED £4,271 ACHILLES THERAPEUTICS UK LIMITED £900 Achira Labs Pvt Ltd £240 ACI GROUP LTD £1,962 ACIC EUROPE LIMITED £2,735 ACINO AG £4,427 ACKERS CHEMISTS LIMITED £288 ACLARDIAN LIMITED £288 ACLARIS THERAPEUTICS INTERNATIONAL LIMITED £9,710 ACLE MEDICAL PARTNERSHIP £288 ACM Biolabs £1,096 ACM Global laboratories £1,876 ACME PHARMA LIMITED £288 ACME VAPE LTD -£9,150 Acon Laboratories Inc. £1,203 ACORN HEALTH PRODUCTS £225 ACRAF SPA- AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO £12,470 ACRE PHARMA LIMITED £3,453 Acro Biotech Inc £336 ACTAVIS GROUP HF £2,428 ACTAVIS GROUP PTC EHF £555,585 ACTELION PHARMACEUTICALS LIMITED £13,680 ACTELION PHARMACEUTICALS UK LIMITED £594 ACTELION REGISTRATION LIMITED £6,310 ACTIVASE PHARMACEUTICALS LIMITED £83,981 ACTREVO GMBH -£13,195 ACURABLE LIMITED £3,820 ACURE PHARMACEUTICALS LIMITED £45,387 ACUTUS LABORATORIES LIMITED £9,600 ADACT MEDICAL LIMITED £1,350 ADALLEN PHARMA LIMITED £288 Adaltis SRL £2,468 ADAM MYERS LIMITED £545 ADAM MYERS SOLUTIONS LIMITED £0 ADAPTIMMUNE LIMITED £8,479 ADAPTIMMUNE LLC £3,960 ADC BIOTECHNOLOGY LIMITED £22,568 ADDENBROOKES HOSPITAL TRUST £492 ADEC MARINE LIMITED £1,626 ADELPHI GROUP LIMITED £94,800 ADEPTIO PHARMACEUTICALS LIMITED £550 Adeste Industria De Produtos Animais LTDA £4,605 ADI PHARMA LIMITED £2,224 Adicet Bio, Inc £456 Adimmune Corporation £208,723 ADM HEALTHCARE LIMITED £3,739 ADMA Biologics, Inc. £13,704 ADOH BV £750 ADT Altona Diagnostic Technologies GmbH £2,467 ADVANCE PHARMACIES LIMITED £288 ADVANCED ACCELERATOR APPLICATIONS £15,086 Advanced Accelerator Applications (Italy) S.R.L £2,304 ADVANCED ACCELERATOR APPLICATIONS (SWITZERLAND) SA £900 ADVANCED ACCELERATOR APPLICATIONS (UK & IRELAND) LIMITED £13,286 Advanced BioMedical Laboratories, LLC £94 ADVANCED CLINICAL RESEARCH SERVICES LIMITED £1,350 ADVANCED DEVELOPMENT & SAFETY LABORATORIES LIMITED £5,006 ADVANZ PHARMA GENERICS (UK) LIMITED £3,417 Advy Chemical Pvt. Ltd. £475 AEGERION PHARMACEUTICALS LIMITED £2,655 AEGLEA BIOTHERAPEUTICS INCORPORATED £4,487 AEGLEA BIOTHERAPEUTICS UK LIMITED £3,060 AEM LIMITED £3,668 AENOVA IP GMBH £442 AERO HEALTHCARE LIMITED £288 AERONA CLINICAL LIMITED £288 AEROPAK (CHEMICAL PRODUCTS) LIMITED £982 AESICA FORMULATION DEVELOPMENT LIMITED £0 AESICA PHARMACEUTICALS LIMITED £1,285 AESICA QUEENBOROUGH LIMITED £25,386 Aesku Diagnostics GmbH & Co. KG £1,987 AFDOS PHARMACEUTICALS LIMITED £13,051 AFFIMED THERAPEUTICS AG £4,487 Affinity Biologicals Inc. £9,200 AFIMMUNE LIMITED £225 AG PHARMAHEALTH LIMITED £288 Agappe Diagnostics Ltd £168 AGB-PHARMA AB £42,730 AGC Biologics, Inc. £168 AGCT GmbH £2,584 Agence Francaise de Lutte Contre le Dopage - AFLD £648 Agencia Espanola de Medicamentos Y Productos £3,156 AGENCY FOR MEDICINAL PRODUCTS AND MEDICAL DEVICES £10,000 AGENDA RESOURCE MANAGEMENT LIMITED £2,876 AGES - Austrian Agency for Health & Food Safety £12,318 AGHALEE PHARMACY PRACTICE LIMITED £288 AGILITY LOGISTICS LIMITED £3,967 Agnitio Science & Technology Inc £408 AGROCHEMEX LIMITED £5,310 AGUETTANT LIMITED £774 AH UK ANIMAL HEALTH (PVT) LIMITED £5,432 AHP MEDICAL SUPPLIES LIMITED £240 AiLife Diagnostics, Inc. £312 AIM RX LIMITED £288 AIN PHARMA LTD £316 Ainia Centro Tecnologico £168 AINSWORTHS (LONDON) LIMITED £1,918 AIR LIQUIDE LIMITED £3,987 AIR LIQUIDE SANTE INTERNATIONAL £1,713 AIR PRODUCTS PLC £1,647 AIREDALE GENERAL HOSPITAL £492 AIREDALE NHS FOUNDATION TRUST £971 Airmid Healthgroup Ltd £436 AIRMUST -£1,500 AIRSCREAM UK LIMITED £3,150 AJ Roboscreen GmbH £454 AJ Vaccines A/S £579 AJ VACCINES AS £6,373 Ajinomoto Althea, Inc £288 AK SONS TRADING LIMITED £288 Akershus University Hospital £292 AKIVA -£600 AKRO PHARMACEUTICAL COMPANY LIMITED £2,108 Akron Biotechnology, LLC £1,845 AKTIVE HEALTHCARE LIMITED £2,710 AL MEDICINES LIMITED £288 Alamar Biosciecnes, Inc. £120 ALAMAZ LIMITED £288 ALAN BOYD CONSULTANTS LIMITED £18,752 ALAN SPIVACK LIMITED £886 ALANIC ENGINEERING LIMITED £288 ALBANY MOLECULAR RESEARCH (GLASGOW) LIMITED £1,450 ALBANY PRODUCTS LIMITED £172 ALBERT CROSS LIMITED £288 ALBERT HARRISON & COMPANY LIMITED £172 Albila Serum Biyolojik Urunler San ve Tic AS £428 ALBUMEDIX LIMITED £932 ALCAMI CORPORATION £288 ALCON EYE CARE UK LIMITED £10,029 ALCONBURY AND BRAMPTON SURGERIES £288 ALCURA UK LIMITED £1,260 ALD GROUP LIMITED £1,200 ALDER HEY CHILDREN'S NHS FOUNDATION TRUST £1,850 ALDERLEY ANALYTICAL LIMITED £1,380 ALEXANDRA HOSPITAL £492 ALEXION EUROPE SAS £27,095 ALEXION PHARMA GMBH £17,889 ALEXION PHARMA UK LIMITED £2,224 ALFA (WHOLESALE) LIMITED £172 ALFA CHEMICALS LIMITED £514 ALFA CHEMISTS LIMITED £288 ALFA LABS LIMITED £92,100 Alfa Scientific Designs Inc. £336 Alfachem SRL £648 ALFASIGMA SPA £19,424 ALFRAPHARMA S.R.L. £33,838 ALFRED E TIEFENBACHER GMBH & CO KG £108,096 AL-GHANI LIMITED £288 Algimed Trade LTD £1,440 Alifax S.R.L. £240 Aligos Belgium bvba £214 ALIMENTIV B.V. £450 ALIMENTIV INC. £225 ALIMERA SCIENCES LIMITED £5,290 ALISSA HEALTHCARE RESEARCH LIMITED £116,078 ALIUM MEDICAL LIMITED £3,023 Alk - Abello (UK) Limited £41,500 ALK ABELLO A-S £64,661 ALK Source Materials £336 ALK-ABELLO LIMITED £2,622 ALKALOID-INT DOO £34,794 Alkor Impex Ltd £2,768 ALL DAY PHARMACY LLP £576 ALL VAPE LIMITED £2,700 ALLCURES PLC £288 ALLEGRO DISTRIBUTION £2,821 ALLERGAN £628 ALLERGAN BIOLOGICS LIMITED £468 ALLERGAN INCORPORATED £272 ALLERGAN LIMITED £54,581 ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED £36,543 ALLERGAN PHARMACEUTICALS IRELAND £15,747 ALLERGOPHARMA GMBH & CO KG £2,428 ALLERGY THERAPEUTICS (UK) LIMITED £32,498 ALLIANCE HEALTHCARE (DISTRIBUTION) LIMITED £5,906 ALLIANCE MEDICAL LIMITED £774 ALLIANCE MEDICAL MOLECULAR IMAGING LIMITED £468 ALLIANCE MEDICAL RADIOPHARMACY LIMITED £13,836 ALLIANCE PHARMACEUTICALS LIMITED £98,399 ALLIED PHARMACIES LIMITED £12,390 ALLOGA UK LIMITED £11,261 ALLONE PHARMA LIMITED £2,838 ALMAC CLINICAL SERVICES LIMITED £19,422 ALMAC GROUP LIMITED £2,400 ALMAC PHARMA SERVICES LIMITED £31,479 ALMAC SCIENCES (SCOTLAND) LIMITED £514 ALMAC SCIENCES LIMITED £3,102 ALMIRALL HERMAL GMBH £22,101 ALMIRALL LIMITED £288 ALMIRALL SA £22,490 Alnylam Pharmaceuticals, Inc. -£266 ALNYLAM UK LIMITED £10,978 Alpco Diagnostics £1,056 ALPEX PHARMA (UK) LIMITED £10,177 ALPEX PHARMA SA £152 ALPHA ANALYTICAL LABORATORIES LIMITED £3,983 ALPHA BIORESEARCH SL £3,820 Alpha Diagnostic Intl. £2,732 ALPHA PHARMACEUTICALS LTD £3,739 ALPHARMA LIMITED £288 ALS LABORATORIES (UK) LIMITED £5,310 AL-SHIFA TRADING LIMITED £288 ALSTON GARRARD AND COMPANY LIMITED £1,109 ALTAN PHARMA LIMITED £65,967 Altasciences Company Inc. £648 ALTHEA UK AND IRELAND LIMITED £774 ALTIEX LIFE SRO £60,688 ALTNAGELVIN HOSPITAL £492 ALTOVIDA BIOSCIENCES LIMITED £288 ALTURIX LIMITED £288 ALUMIER MEDICAL
Load more

Recommended publications
  • Annual Report 2018-19 80Th Year Contents
    Accelerating focussed growth Integrated Annual Report 2018-19 80th Year Contents Integrated Report Deep innovation expertise to harness the 01-57 best of science and serve the society. 01 Company Overview A passion to consistently push beyond 06 Our Diversified Science Led Portfolio 08 Performance Highlights for FY 2018-19 existing limits and rise above. 10 Board of Directors Combine innovation and passion with scale 12 Management Team and accelerated growth happens. 13 MD & CEO's Message 14 Integrated Value Chain This is how Tata Chemicals has emerged to be one of the world’s most reputed brands, revolutionising the 16 Business Model Explaining the Interlinkage of Capitals industry segments it has operated in its 18 Our Formula for Accelerating 80-year journey. Focussed Growth As we continue to nurture our inherent strengths, 21 Managing Risks, Maximising Returns we are undertaking many initiatives to accelerate our 24 Listening to and Engaging growth in focussed areas. with the Stakeholders 25 Addressing Material Issues Our multi-pronged strategy of customer-centric 26 Basic Chemistry Business product development and expansion into white spaces in our Consumer Products Business and capacity 32 Consumer Products Business augmentation programmes in our Specialty Products 38 Specialty Chemicals Business Business has laid a strong foundation for growth. 45 Intensifying Focus on Health & Safety Aligning our organisational structure and strategies 46 Innovating for a Better World with the revised segment reporting and the exit from 48 Growing Together non-core businesses has simplified our portfolio and are 50 Our Commitment to driving stronger synergies. Strong innovation drive is Sustainable Growth enabling us to tap the emerging areas and 53 Corporate Social Responsibility nurture the newly-seeded portfolio.
    [Show full text]
  • Delivering Today. Innovating for Tomorrow
    DELIVERING TODAY. INNOVATING FOR TOMORROW. INVESTING IN OUR FUTURE. CUSTOMER NEWS NOVEMBER 2017 A ENTERPRISE Following a strategic review in 2011, TCE has undertaken major change in our business over the last few years. From being primarily a soda ash business, we A message from our shareholder have transformed into a broad diversified soda ash, sodium bicarbonate and salt business delivering reliable high quality products into increasingly diverse markets. “Our team at Tata Chemicals Europe have worked We have built a strong and sustainable cost base, made possible by a hugely engaged tirelessly to deliver a robust and passionate workforce. We have acquired British Salt Limited, built the first stand- and diverse business. On alone sodium bicarbonate plant of its kind, established a major soda ash import facility as behalf of the Shareholder a virtual factory to support our indigenous manufacturing plant in Northwich, invested we are excited to support heavily in new supply chain solutions, and implemented a major package of business and the investment plans for the coming 5 process improvements. years across TCE’s soda ash, bicarb and salt businesses. Next year will be 150 years of Significantly we have been able to take control of our own energy supplies for our soda Tata and as we look forward to that event, ash and sodium bicarbonate businesses by acquiring from EoN the gas-fired CHP plant we wish to thank you very much for your at our Winnington site. Having the CHP plant and our soda ash and sodium bicarbonate continued support of our TCE business.” facilities under common ownership and control has driven far greater efficiency, cost R Mukundan, Managing Director control and reliability for these businesses.
    [Show full text]
  • Register of GDP Sites 2019
    Register of GDP Sites 2019 Updated 16 August 2019 There are other sites authorised for wholesale dealing of veterinary medicinal products which do not appear on this register. These sites wholesale deal in both human and veterinary medicinal products and can be found on the MHRA section of GOV.UK: https://www.gov.uk/government/publications/human-and-vetinary-medicines- register-of-licensed-wholesale-distribution-sites-december-2014 Register of Authorised Wholesale Dealer Sites Authorisation Holder: WDA33618 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0415 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0010 ABBEYVET LLP SHERBURN ENTERPRISE PARK, SHERBURN IN ELMET, LEEDS, WEST YORKSHIRE, LS25 6NB Authorisation Holder: WDA8599 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN SITE ID: S0015 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN Authorisation Holder: WDA5097 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0456 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0525 CVS GROUP PLC CVS HOUSE, OWEN ROAD, DISS, NORFOLK, IP22 4ER Authorisation Holder: WDA5030 ALBERT E JAMES & SON LIMITED BARROW MILL BARROW STREET, BARROW GURNEY, BRISTOL, BS48 3RU SITE ID: S0303 ALBERT E JAMES &
    [Show full text]
  • United States Securities and Exchange Commission Form 10-K Shire Pharmaceuticals Group
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ፤ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 1999 អ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification No.) N.A. East Anton, Andover, Hampshire SP10 5RG England (Address of principal executive offices) (Zip Code) 44 1264 333455 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depository Shares, each representing Nasdaq National Market 3 Ordinary Shares, 5 pence nominal value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ፤ No អ Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant's knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • Listing of Global Companies with Ongoing Government Activity
    COMPANY LINE OF BUSINESS TICKER A & A BIOTECHNOLOGY S C ADAM BURKIEWICZ MIKOLAJ BURKIEWICZ PHARMACEUTICAL PREPARATIONS A & A GLOBAL INDUSTRIES, INC. AUTOMATIC VENDING MACHINES, NSK A & J ENTERPRISES PHARMACEUTICAL PREPARATIONS A & S INTERNATIONAL 2000 S.R.L. PHARMACEUTICAL PREPARATIONS A & S PHARMACEUTICAL CORP. PHARMACEUTICAL PREPARATIONS A & T MARKETING INC. COMPUTER INTEGRATED SYSTEMS DESIGN, NSK A & T SYSTEMS, INC. TELEPHONE COMMUNICATION, EXCEPT RADIO A & Z PHARMACEUTICAL INC. PHARMACEUTICAL PREPARATIONS A A INTERNATIONAL PHARMACEUTICAL PREPARATIONS A AND V, INC. BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC A AROGYA HARBALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A B ENTERPRISES PHARMACEUTICAL PREPARATIONS A B I HERBAL PRODUCTS MEDICINALS AND BOTANICALS, NSK A B S REMEDIES PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A BEAT FOR YOUR FEET, INC. COIN-OPERATED LAUNDRIES AND CLEANING, NSK A BUCKHEAD BUS COMPANY LOCAL PASSENGER TRANSPORTATION, NEC A C C VIEIRA PROTESE ME MEDICINALS AND BOTANICALS, NSK A C CONSULTING PHARMACEUTICAL PREPARATIONS A C E DIAGNOSTICS & BIOTECH LIMITED PHARMACEUTICAL PREPARATIONS A C E PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A C PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A CUT ABOVE LANDSCAPE LAWN AND GARDEN SERVICES A D C O MARKETING INC NONDURABLE GOODS, NEC, NSK A G HERBALS PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A G PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A H C PHARMACAL, INC PHARMACEUTICAL PREPARATIONS A H SYSTEMS INC INSTRUMENTS TO MEASURE ELECTRICITY A HOUSE OF AYURVEDIC
    [Show full text]
  • CRR 446/2002 a Study of the Provision of Health and Safety Information in the Annual Reports of the Top UK Companies
    HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Prepared by System Concepts Ltd for the Health and Safety Executive CONTRACT RESEARCH REPORT 446/2002 HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Laura Peebles, Ansgar Kupper and Tanya Heasman System Concepts Ltd 2 Savoy Court Strand London WC2R 0EZ This report details the findings of a research project to investigate the quality and quantity of health and safety information found in the annual reports of the top UK companies. At present, publicly listed companies are not legally required to include health and safety matters in their annual reports. The current Health and Safety Commission (HSC) Strategy Statement, however, contains an action point which focuses on public reporting of health and safety issues by larger companies. The aim is to promote the reporting of health and safety information in company annual reports and to provide guidance that would allow reporting of such information to a common standard. To assist the HSC with this strategy, System Concepts were commissioned by the Health and Safety Executive (HSE) to undertake an investigation of the provision of health and safety information in company annual reports. The study comprised a series of steps. The main objectives of the study were: i) To determine the current level of reporting of health and safety issues in annual reports of the top UK companies ii) To determine the quality of health and safety information reported.
    [Show full text]
  • Rape Research
    Rape Research After scene 2, in Paulson‘s Tavern, Tara is left behind whilst it empties out. This is the perfect setting for Danni to tranquilise her with a date rape drug. This is quite a strong subject, and I felt like the whole group should put more research and get a greater understanding, so we know how to deal with the situation and portray it through our performance. Personally, I have never known anyone who has experienced this situation before, so to ensure that I would create a believable performance and reaction, I needed to get a greater understanding and look at interviews, dramas and information about date rape and the affect it has on people‘s lives. BBC Health – Rohypnol http://www.bbc.co.uk/health/physical_health/conditions/rohypnol.shtml What is Rohypnol? Rohypnol is the brand name of a medicine called flunitrazepam, and is one of the benzodiazepine class of sedative or tranquilizer drugs, of which ‗Valium‘ or diazepam is perhaps the best known. Rohypnol or flunitrazepam is 10 times more potent than diazepam. In the UK the drug is no longer used in the NHS but may be available on private prescription for those who need it (although it‘s generally felt that there are better alternatives). Its legal status in the UK is a class C drug, which means that it‘s illegal to possess flunitrazepam without a prescription. It‘s not legally available in the US, but as it is still made in some countries an illegal trade continues. Rohypnol rose to prominence as the date rape drug because it was colourless, odourless, tasteless and easily dissolved - ideal for spiking drinks undetected - and causes sedation or euphoria in approximately 20 to 30 minutes.
    [Show full text]
  • Chapter-I Introduction
    CHAPTER-I INTRODUCTION 1 INTRODUCTION Tata Group Type Private Industry Conglomerate Founded 1868 Founder(s) Jamsetji Tata Bombay,house Headquarters Mumbai, India Area served Worldwide RatanTata Key people (Chairman) Steel Automobiles Telecommunications Products Software Hotels Consumer goods 2 Revenue 319,534 crore (US$69.34 billion) Profit 8,240 crore (US$1.79 billion) Total assets US$ 52.8 billion (2009-10) Employees 396,517 (2009-10) TataSteel TataSteelEurope TataMotors TataConsultancyServices TataTechnologies TataTea Subsidiaries TitanIndustries TataPower TataCommunications TataTeleservices TataAutoCompSystemsLimited Taj Hotels Website Tata.com Tata Group Companies CMC · Tata BP Solar · Tata Coffee · Tata Chemicals · Tata Consultancy Services · Tata Elxsi · Tata Interactive Systems · Tata Motors · Tata Steel · Tata Power · Tata India-basedTea · Tata Communications · Tata Technologies Limited · Tata Teleservices · Titan Industries · Tata Voltas · The Indian Hotels Company · Trent (Westside) · Cromā 3 Brunner Mond · Jaguar Land Rover (Jaguar Cars · Land Other Rover) · Tata Daewoo Commercial Vehicle · Tata Steel Europe · Tetley · VSNL International Canada Ginger · Good Earth Teas · Tanishq · Taj Hotels · I-shakti · Tata Salt · Brands Tata Sky · Tata Indicom · Tata DoCoMo · Titan · Westside · Voltas · Virgin Mobile India Notable Jamsetji Tata · Ratanji Dadabhoy · Dorabji Tata · Nowroji People Saklatwala · J. R. D. Tata · Ratan Tata · Pallonji Mistry Bombay House is the head office of Tata Group The Tata Group is an Indian multinational conglomerate company headquartered in the Bombay House in Mumbai, India. In terms of market capitalization and revenues, Tata Group is the largest private corporate group in India. It has interests in chemicals, steel, automobiles, information technology, communication, power, beverages, and hospitality. The Tata Group has operations in more than 80 countries across six continents and its companies export products and services to 80 nations.
    [Show full text]
  • Cold Chain Distribution Conference and Exhibition Enhance Temperature Management for an Efficient Supply Chain
    SMi PRESENTS THE 9TH ANNUAL COLD CHAIN DISTRIBUTION CONFERENCE AND EXHIBITION ENHANCE TEMPERATURE MANAGEMENT FOR AN EFFICIENT SUPPLY CHAIN 2ND - 3RD DECEMBER 2014 | MARRIOTT REGENTS PARK, LONDON UK Sponsorship Manual www.coldchain-distribution.com “ A very well organised event. Professional team and well executed” Cold Chain Delegate 2013 9th annual Cold Chain Distribution Conference and Exhibition Drawing on 8 years of working within the Cold Chain Logistics industry, the SMi Group are delighted to announce their 9th annual Cold Chain Distribution Conference and Exhibition. Join this event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. Benefits of Attending: ● Benchmark and reflect on the implementation of the GDP directive with case studies from IATA, AbbVie and the Dutch Health Care Inspectorate ● Enhance your understanding of the challenges of transport qualification for temperature sensitive pharmaceutical products with a round table discussion led by Tony Wright, Managing Director, Exelsius Cold Chain Management and an opening address from Alan Dorling, Global Head – Pharmaceutical & Life Sciences, IAG Cargo ● Strengthen your supply chain through management and efficiency insights from Merck Serono and Genzyme ● In addition, Cold Chain Distribution
    [Show full text]
  • 2017-18 About This Report
    59 2017-18 79th Annual Report Report Annual 79th www.linkedin.com/Company/tata-chemicals www.tcsrd.com www.twitter.com/TataChemicals www.okhai.org www.facebook.com/humantouchofchemistry www.tatanx.in www.facebook.com/TataChemicals www.tataswach.com www.tatachemicals.com www.tatasampann.com www.tatasalt.com www.humantouchofchemistry.com Fax: +91 22 6665 8144 Telephone: +91 22 6665 8282 CIN: L24239MH1939PLC002893 Mumbai - 400001 India. Homi Mody Street, Fort, Bombay House, 24, Registered Address Financial Statements Statutory Reports Transform Grow Grow Integrated Report About this report Tata Chemicals seeks to go beyond compliance in its corporate reporting. Alongside statutory declarations, this Annual Report includes non-financial information that is disclosed on a voluntary basis in accordance with the Integrated Reporting <IR> framework of International Integrated Reporting Council (IIRC). Assurance on financial statements has been provided by independent auditors B S R & Co. LLP and non- financial statements by Ernst & Young LLP. Monitoring marine turtle mortality and nesting along the Okhamandal coast Contents Integrated Report Introduction 2 Ethics 39 Highlights at a glance 3 Peoples practices 40 Company overview 4 Community 42 MD's message 6 Sustainability 46 Performance highlights 7 Risks 49 Materiality 8 Board of Directors 50 Value creation 10 Management team 52 Strategy and KPIs 12 Basis of report preparation 53 Forward looking statements 53 Consumer products Assurance notice 54 Business overview 16 Results at a glance 56 Case
    [Show full text]
  • SHIRE PHARMACEUTICALS GROUP PLC (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales 98-0359573 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Hampshire International Business Park, Chineham, +44 1256 894 000 Basingstoke, Hampshire, England, RG24 8EP (Registrant’s telephone number, including area code) (Address of principal executive offices and zip code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depositary Shares, each representing 3 NASDAQ National Market Ordinary Shares 5 pence par value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • University of Strathclyde Beats LBS and Oxford in Finals
    Victorious University of Strathclyde repeats history at 4th UK edition of Tata Crucible Campus Quiz UK champions win a second opportunity to travel to India for the international finals, along with newcomers ESCP Europe London, 20th November 2011: The team of Anup Nair and Michael Doroszenko from The University of Strathclyde emerged as champions for the second year in a row at the 4th annual UK Tata Crucible, a major business quiz designed to encourage lateral thinking and test commercial awareness for the country’s future business leaders. The pair from Strathclyde impressed the audience and Quiz Master ‘Pickbrain’ with a confident win, fighting off a spirited challenge from the second place team of ESCP Europe and third place team of London Business School (LBS), with the championship title being decided only on the last question of the evening. Amongst this year’s special guests were Dr Ralph Speth, CEO of Jaguar Land Rover, who expressed fascination with the power of the questions and the excitement of the evening, while emphasizing the crucial role that young talent plays in the future success of companies. This year’s chief guest was Jo Johnson, MP for Orpington and former India Bureau Chief for the Financial Times. Awarding the winners with their prizes, Mr Johnson said “It is a very inspiring evening. I am just awe-struck, by not just the knowledge, the factual knowledge that our contestants had, but the ingenuity and the creativity that they displayed in all of their answers”. He urged the students to strive for excellence to achieve success and added “Keep on displaying the sheer enthusiasm for the subject matter and the creativity and ingenuity I just referred to and the world will be yours”.
    [Show full text]